查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301150

美国氯胺酮诊所市场规模、份额和趋势分析报告：按疗法、按治疗、细分市场预测，2023-2030 年

U.S. Ketamine Clinics Market Size, Share & Trends Analysis Report By Treatment (Depression, Anxiety, PTSD), By Therapy (On-site Therapy, Online Therapy), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

美国氯胺酮诊所市场增长和趋势

美国氯胺酮诊所市场预计到 2030 年将达到 69 亿美元。

从 2023 年到 2030 年，该市场预计将以 10.63% 的复合年增长率增长。 根据药物滥用和心理健康服务管理局 (SAMHSA) 的数据，18 至 25 岁的年轻人中约有 13% 患有精神疾病或药物滥用问题。 此外，四分之一的美国人患有精神疾病，三分之一的美国人患有药物滥用障碍。 患有成瘾和精神障碍的人数不断增加，导致了这一增长。

COVID-19 大流行对在线氯胺酮治疗诊所产生了巨大影响。 在线诊所面临诊所关闭、供应链中断和担心病毒传播等问题。 因此，许多人避免去诊所和医院。 然而，大流行导緻美国的心理健康问题急剧上升，人们面临着更大的压力、焦虑和抑郁。 日常生活的干扰、社会孤立以及经济和就业压力的增加导致精神健康障碍的增加。 根据美国心理健康 (MHA) 的数据，2020 年 1 月至 9 月在美国接受筛查的人中，35% 的人患有抑郁症，20% 的人患有焦虑症。

美国氯胺酮诊所行业的主要参与者正在实施各种战略，包括併购、合作、业务扩张和推出新服务，以扩大其市场份额。 这些努力预计将有助于市场增长。 例如，2023 年 4 月，提供氯胺酮疗法的 Mindbloom, Inc. 与基于技术的管理咨询公司 SHIFT 合作。 作为此次合作的一部分，SHIFT 员工现在能够以折扣价接受 Mindbloom 的家庭氯胺酮治疗。 该计划旨在为 SHIFT 员工提供宝贵的福利。

美国氯胺酮诊所市场报告亮点

  • 从治疗角度来看，由于患有严重抑郁症的美国成年人数量不断增加，抑郁症细分市场将在 2022 年占据最大的市场份额
  • 预计焦虑部分在预测期内增长最快。 焦虑症是美国最常见的精神疾病。 因此，对焦虑症的治疗和支持的需求不断增长，预计这将推动该行业的增长。
  • 按治疗计算，现场治疗细分市场在 2022 年占据最大市场份额。 人们对氯胺酮治疗精神疾病的接受度提高，导緻美国氯胺酮诊所的扩张，进一步推动了该行业的增长。
  • 在线治疗领域的增长对整个美国氯胺酮诊所行业产生了重大影响。 远程医疗和远程医疗保健服务的兴起极大地扩展了在线氯胺酮治疗的可及性和便利性。

内容

第一章调查方法及范围

  • 市场细分和范围
    • 市场定义
  • 估计/预测时间表
  • 调查方法
  • 信息获取
    • 购买的数据库
    • GVR 内部数据库
    • 二手信息和第三方观点
    • 初步调查
  • 信息分析
    • 数据分析模型
  • 市场形成和数据可视化
  • 型号详细信息
  • 辅助信息列表

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第三章市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 相关/补充市场前景
  • 市场趋势和展望
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
  • 商业环境分析
    • 杵分析
    • 波特五力分析
  • COVID-19 感染的影响分析

第 4 章治疗业务分析

  • 氯胺酮诊所市场：2022 年和 2030 年治疗变化分析和市场份额
  • 抑郁症
  • 焦虑
  • 创伤后应激障碍
  • 其他

第5章处理业务分析

  • 氯胺酮诊所市场：2022 年和 2030 年治疗变化分析和市场份额
  • 现场治疗
  • 在线治疗

第 6 章竞争格局

  • 公司分类
  • 战略规划
    • 扩展名
    • 获取
    • 合作
    • 推出新产品
    • 其他
  • 公司简介/列表
    • NY Ketamine Infusions
    • Field Trip Health and Wellness Ltd.
    • Ketamine Clinics Los Angeles
    • Klarity Clinic
    • Vitalitas Denver Ketamine Centers
    • Mindbloom, Inc
    • Nue Life Health
    • Better U, LLC
    • Innerwell
    • Klarisana

第 7 章建议/主要市场洞察

Product Code: GVR-4-68040-092-1

U.S. Ketamine Clinics Market Growth & Trends

The U.S. ketamine clinics market size is expected to reach USD 6.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 10.63% from 2023 to 2030. The market is experiencing significant growth, driven by factors such as increasing mental health awareness, the ongoing opioid crisis, and expanding number of ketamine clinics across the U.S. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), about 13% of young adults aged 18 to 25 have mental or substance use problems. Additionally, 1 in 4 Americans have a mental illness, and 1 out of 3 have a substance use disorder. The increasing number of people with addictions and mental health disorders is contributing to the growth.

The COVID-19 pandemic had a significant impact on online ketamine therapy clinics. While onsite providers faced challenges such as lockdowns, disruptions in the supply chain, and people's fear of contracting the virus. Consequently, many individuals avoided visiting clinics or hospitals. However, the pandemic led to a surge in mental health issues in the U.S. as people faced increased stress, anxiety, and depression. Disruptions in daily routines, social isolation, and increased stress related to finances and employment contributed to a rise in mental health disorders. According to Mental Health America (MHA), 35% of the people screened in the U.S. from January to September 2020 reported having depression, while 20% reported experiencing anxiety.

Key players in the U.S. ketamine clinics industry are implementing various strategies such as mergers & acquisitions, partnerships, expansions, and launching new services to expand their market presence. These efforts are expected to contribute to the market's growth. For instance, in April 2023, Mindbloom, Inc., a ketamine therapy provider, partnered with SHIFT, a tech-based management consulting company. As part of this partnership, SHIFT employees will now have the opportunity to receive at-home ketamine therapy from Mindbloom at a reduced cost compared to the regular price. This initiative aims to provide a valuable benefit to SHIFT employees.

U.S. Ketamine Clinics Market Report Highlights

  • Based on the treatment, the depression segment held the largest market share in 2022 owing to the growing number of American adults burdened with severe major depression
  • The anxiety segment is anticipated to witness the fastest growth over the forecast period. Anxiety disorders are the most widespread mental illness in the U.S. As a result, there is an increased need for treatment and support for anxiety disorders, which is expected to drive the segment's growth
  • Based on the therapy, the on-site therapy segment held the largest market share in 2022. Growing acceptance of ketamine therapy for mental health disorder is led to an expansion of ketamine clinics in the U.S., further driving the segment growth
  • The growth of the online therapy segment significantly impacted the overall U.S. ketamine clinics industry. With the rise of telehealth and remote healthcare services, the accessibility and convenience of online ketamine therapy have expanded significantly

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources & Third-Party Perspectives
    • 1.4.4. Primary Research
  • 1.5. Information Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Treatment Business Analysis

  • 4.1. Ketamine Clinics Market: Treatment Movement Analysis & Market Share, 2022 & 2030
  • 4.2. Depression
    • 4.2.1. U.S. Depression Market, 2018 - 2030 (USD Million)
  • 4.3. Anxiety
    • 4.3.1. U.S. Anxiety Market, 2018 - 2030 (USD Million)
  • 4.4. PTSD
    • 4.4.1. U.S. PTSD Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. U.S. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Therapy Business Analysis

  • 5.1. Ketamine Clinics Market: Therapy Movement Analysis & Market Share, 2022 & 2030
  • 5.2. On-Site Therapy
    • 5.2.1. U.S. On-Site Therapy Market, 2018 - 2030 (USD Million)
  • 5.3. Online Therapy
    • 5.3.1. U.S. Online Therapy Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
    • 6.2.1. Expansion
    • 6.2.2. Acquisition
    • 6.2.3. Collaborations
    • 6.2.4. New Product Launches
    • 6.2.5. Others
  • 6.3. Company Profiles/Listing
    • 6.3.1. NY Ketamine Infusions
      • 6.3.1.1. Overview
      • 6.3.1.2. Financial Performance
      • 6.3.1.3. Product Benchmarking
      • 6.3.1.4. Strategic Initiatives
    • 6.3.2. Field Trip Health and Wellness Ltd.
      • 6.3.2.1. Overview
      • 6.3.2.2. Financial Performance
      • 6.3.2.3. Product Benchmarking
      • 6.3.2.4. Strategic Initiatives
    • 6.3.3. Ketamine Clinics Los Angeles
      • 6.3.3.1. Overview
      • 6.3.3.2. Financial Performance
      • 6.3.3.3. Product Benchmarking
      • 6.3.3.4. Strategic Initiatives
    • 6.3.4. Klarity Clinic
      • 6.3.4.1. Overview
      • 6.3.4.2. Financial Performance
      • 6.3.4.3. Product Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Vitalitas Denver Ketamine Centers
      • 6.3.5.1. Overview
      • 6.3.5.2. Financial Performance
      • 6.3.5.3. Product Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. Mindbloom, Inc
      • 6.3.6.1. Overview
      • 6.3.6.2. Financial Performance
      • 6.3.6.3. Product Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Nue Life Health
      • 6.3.7.1. Overview
      • 6.3.7.2. Financial Performance
      • 6.3.7.3. Product Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Better U, LLC
      • 6.3.8.1. Overview
      • 6.3.8.2. Financial Performance
      • 6.3.8.3. Product Benchmarking
      • 6.3.8.4. Strategic Initiatives
    • 6.3.9. Innerwell
      • 6.3.9.1. Overview
      • 6.3.9.2. Financial Performance
      • 6.3.9.3. Product Benchmarking
      • 6.3.9.4. Strategic Initiatives
    • 6.3.10. Klarisana
      • 6.3.10.1. Overview
      • 6.3.10.2. Financial Performance
      • 6.3.10.3. Product Benchmarking
      • 6.3.10.4. Strategic Initiatives

Chapter 7. Recommendations/Key Market Insights

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. ketamine clinics market, by treatment, 2018 - 2030 (USD Million)
  • Table 4. U.S. ketamine clinics market, by therapy, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 US ketamine clinics market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 U.S. ketamine clinics market: Treatment outlook and key takeaways
  • Fig. 17 U.S. ketamine clinics market: Treatment movement analysis
  • Fig. 18 Depression market revenue, 2018 - 2030 (USD Million)
  • Fig. 19 Anxiety market revenue, 2018 - 2030 (USD Million)
  • Fig. 20 PTSD market revenue, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. ketamine clinics market: Therapy outlook and key takeaways
  • Fig. 22 U.S. ketamine clinics market: Therapy movement analysis
  • Fig. 23 On-site therapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 24 Online therapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 25 Company categorization
  • Fig. 26 Strategy mapping
  • Fig. 27 Company market position analysis